Swiss Medica Inc., Innovative Products That Improve Peoples' Lives

10/24/2003 8:15:43 AM ET

SWISS MEDICA SIGNS NATIONAL RETAIL CHAIN NUTRITION HOUSE

FOR IMMEDIATE RELEASE

Stock Symbol: OTC BB:SWME

October 24, 2003

SWISS MEDICA SIGNS NATIONAL RETAIL CHAIN NUTRITION HOUSE

Toronto, Canada – Grant Johnson, President and COO of Swiss Medica, is pleased to announce that Nutrition

House Canada Inc. has signed an agreement to carry Swiss Medica’s O24 Penetrating Pain Relief product in

their retail locations across Canada.

Nutrition House is a Canada-wide national retail chain with over 80 locations and total sales exceeding $50

million and growing. Nutrition House’s mission is to be “your home for quality wellness products and

knowledgeable staff”, and is dedicated to succeeding by providing exceptional natural products to their clients.

“O24 Penetrating Pain Relief from Swiss Medica represents the level of quality product we seek out and provide

to our growing customer base who have come to expect a higher standard of product when they come to

Nutrition House” said Catherine Deslippe, Vice President of Operations for Nutrition House.

“We are very please to have Nutrition House as our first National retail chain for O24. Nutrition House’s owners

and managers are dedicated to providing personal service and quality products to their clients. Nutrition House’s

successful growth is proof enough of the effectiveness of that formula” said Johnson.

“Nutrition House will be a significant part of our efforts to make this remarkable patented product available to

consumers across North America,” further commented Johnson.

About Swiss Medica Inc.

Swiss Medica Inc. is focused on acquiring over-the-counter bioscience products with demonstrated competitive

advantages and increasing their revenues by focused sales and marketing efforts in selected distribution

channels including retail, direct sales, direct response, and e-commerce. Swiss Medica’s mission is to be a world

leader in the acquisition and commercialization of life enhancing bioscience products that improve quality of

lives. Please visit our website at www.swissmedica.com

Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the

United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking

statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close

transactions being contemplated, risks related to international sales and potential foreign currency exchange

fluctuations, continued acceptance of Swiss Medica’s services, increased levels of competition, technological

changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica’s

periodic reports filed with the United States Securities and Exchange Commission and other regulatory

authorities.

Investor Relations Contact:

Dave Jones: 705 495 0022